Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment — Stella
Home / Eosinophilic Asthma / Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment View on ClinicalTrials.gov Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
(157 sites) United States
Research Site, Chandler, Arizona Research Site, Sun City, Arizona Research Site, Tucson, Arizona Research Site, Bakersfield, California Research Site, Inglewood, California Research Site, Modesto, California Research Site, Newport Beach, California Research Site, Pasadena, California Research Site, Denver, Colorado Research Site, Cape Coral, Florida Research Site, Hialeah, Florida Research Site, Lauderdale Lakes, Florida Research Site, Leesburg, Florida Research Site, Miami, Florida Bulgaria
Research Site, Dimitrovgrad Research Site, Stara Zagora Research Site, Stara Zagora Canada
Research Site, Edmonton, Alberta Research Site, Kamloops, British Columbia Research Site, Vancouver, British Columbia Research Site, Ajax, Ontario Research Site, Toronto, Ontario Research Site, Windsor, Ontario Research Site, Québec, Quebec Research Site, Sainte-Foy, Quebec France
Research Site, La Tronche Research Site, Montpellier Research Site, Villeurbanne Germany
Research Site, Geesthacht Research Site, Mönchengladbach Research Site, München-Pasing Research Site, Neu-Isenburg Hong Kong
Research Site, Pok Fu Lam Ireland
Research Site, Ballinasloe Italy
Research Site, Montebelluna Spain
Research Site, Alzira (Valencia) Research Site, Jerez de la Frontera Switzerland
Research Site, Sankt Gallen United Kingdom
Research Site, Birmingham Research Site, Nottingham Research Site, Portsmouth
Key details Enrollment target
~400 participants
Primary completion
November 2027
Age range
12 Years – 75 Years
Last updated March 2026
Interested in joining? Research Site, Miami, Florida
Research Site, Miami, Florida Research Site, Orlando, Florida Research Site, Plantation, Florida Research Site, Tampa, Florida Research Site, Winter Park, Florida Research Site, Ann Arbor, Michigan Research Site, Henderson, Nevada Research Site, Northfield, New Jersey Research Site, Union City, New Jersey Research Site, New Hyde Park, New York Research Site, The Bronx, New York Research Site, Oklahoma City, Oklahoma Research Site, Oklahoma City, Oklahoma Research Site, DuBois, Pennsylvania Research Site, Warwick, Rhode Island Research Site, Greenville, South Carolina Research Site, Houston, Texas Research Site, McKinney, Texas Research Site, San Antonio, Texas Research Site, Qinhuangdao Research Site, Palma de Mallorca